You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy
Active, not recruiting
  • Stage I Chronic Lymphocytic Leukemia
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
2022-03-24
Mar 24, 2022
O
Dasatinib in Treating Patients With Chronic Lymphocytic Leukemia - 2018
Completed
Has Results
  • Refractory Chronic Lymphocytic Leukemia
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
2021-03-15
Mar 15, 2021
O
Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL
Active, not recruiting
  • Contiguous Stage II Small Lymphocytic Lymphoma
  • +11 more
  • MOR00208
  • +2 more
  • Columbus, Ohio
    The Ohio State University Comprehensive Cancer Center
2022-02-24
Feb 24, 2022
N
Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia
Active, not recruiting
Has Results
  • Stage I Chronic Lymphocytic Leukemia
  • +3 more
  • alemtuzumab
  • +2 more
  • Chicago, Illinois
  • +1 more
2020-12-29
Dec 29, 2020
N
Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by Surgery
Active, not recruiting
  • Ann Arbor Stage III Small Lymphocytic Lymphoma
  • +7 more
  • Washington, District of Columbia
  • +1 more
2022-04-05
Apr 5, 2022
M
CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies - 2021
Completed
  • Acute Biphenotypic Leukemia
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-15
Nov 15, 2021
C
Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20 - 2020
Completed
  • Hematopoietic/Lymphoid Cancer
  • +22 more
  • anti-CD19/20-CAR vector-transduced T cells
  • Beijing, Beijing, China
    Biotherapeutic Department and Pediatrics Department of Chinese P
2020-08-31
Aug 31, 2020
C
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant
Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
2022-02-28
Feb 28, 2022
U
Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
Active, not recruiting
  • Adult Grade III Lymphomatoid Granulomatosis
  • +71 more
  • Chicago, Illinois
  • +5 more
2021-10-08
Oct 8, 2021
F
Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - 2016
Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • +8 more
  • Fludarabine Phosphate
  • +3 more
  • Seattle, Washington
  • +1 more
2020-02-14
Feb 14, 2020
F
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Completed
  • Hematopoietic/Lymphoid Cancer
  • +135 more
  • beclomethasone dipropionate
  • +4 more
  • Hackensack, New Jersey
  • +1 more
2021-02-01
Feb 1, 2021
N
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Active, not recruiting
  • Glioma
  • +49 more
  • Duarte, California
  • +11 more
2022-03-01
Mar 1, 2022
F
Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies - 2021
Terminated
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +12 more
  • Laboratory Biomarker Analysis
  • ROR1 CAR-specific Autologous T-Lymphocytes
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-07
Mar 7, 2022
B
Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma - 2015
Completed
Has Results
  • Adult Grade III Lymphomatoid Granulomatosis
  • +88 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
2021-04-14
Apr 14, 2021
U
CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy - 2016
Completed
Has Results
  • Hematopoietic/Lymphoid Cancer
  • +22 more
  • CART-19
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
2019-06-21
Jun 21, 2019
F
Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - 2018
Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • +8 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Rochester, Minnesota
  • +4 more
2019-06-20
Jun 20, 2019
F
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer - 2018
Completed
Has Results
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +173 more
  • fludarabine phosphate
  • +6 more
  • Salt Lake City, Utah
  • +4 more
2020-01-17
Jan 17, 2020
O
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +58 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
2022-02-16
Feb 16, 2022
C
Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22
Unknown status
  • Hematopoietic/Lymphoid Cancer
  • +22 more
  • anti-CD19/22-CAR vector-transduced T cells
  • Beijing, Beijing, China
    Biotherapeutic Department and Pediatrics Department of Chinese P
2019-04-16
Apr 16, 2019
F
Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies - 2009
Completed
Has Results
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +99 more
  • alemtuzumab
  • +6 more
  • Denver, Colorado
  • +6 more
2020-01-15
Jan 15, 2020
C
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload - 2011
Terminated
Has Results
  • Iron Overload
  • +101 more
  • Duarte, California
    City of Hope
2019-06-07
Jun 7, 2019
N
Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Active, not recruiting
  • Ann Arbor Stage I Small Lymphocytic Lymphoma
  • +8 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2022-01-19
Jan 19, 2022
R
Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders - 2019
Completed
Has Results
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +99 more
  • fludarabine phosphate
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2019-10-30
Oct 30, 2019
S
Selenious Yeast in CLL Patients w/o Indication of Chemotherapy
Recruiting
  • Chronic Lymphocytic Leukemia Stage A(0)
  • +3 more
  • Low Dose Selenious Yeast Tablets
  • High Dose Selenious Yeast Tablets
  • Shanghai, Shanghai, China
    Zhongshan Hospital
2021-11-26
Nov 26, 2021
O
A Prognostic Tool for Early Stage CLL - 2020
Completed
  • Chronic Lymphocytic Leukemia
    • Novara, Italy
      Azienda Ospedaliera Universitaria Maggiore della Carità
    2021-09-08
    Sep 8, 2021